Advertisement

Organisation › Details
InfanDx AG, Berlin Office
InfanDx AG is a privately held company focusing on the development and commercialization of novel diagnostic solutions for acute and critical care conditions in newborns. The Company’s proprietary lead product in clinical development is the InfanDx HypoxE® Test designed for the reliable identification of hypoxic-ischemic encephalopathy (HIE) within the first hours of birth. HIE as a consequence of perinatal asphyxia (oxygen deficit during birth) can result in life-long disabilities. The long-term detrimental effects of HIE can be mitigated and even prevented by neuroprotective hypothermia treatment. However, this therapy must be initiated within six hours of birth to be effective, requiring suitable diagnostic methods to reliably and timely identify the affected newborns. While standard-of-care diagnostic methods cannot deliver a conclusive diagnosis of HIE within this time frame, the rapid InfanDx HypoxE® Test is designed to support clinicians in the timely decision whether newborns require neuroprotective hypothermia treatment. The Company is headquartered in Cologne, Germany, with a branch office in Berlin, Germany, and a wholly-owned subsidiary in Boston, MA, USA. *
![]() |
Start | 2022-03-15 existent |
Group | InfanDx (Group) | |
![]() |
Industry | neonatal test |
Industry 2 | biomarker | |
![]() |
Person | Plum, Achim (High-Tech Gründerfonds 202501– Managing Director before InfanDx + SphingoTec + Curetis/OpGen + Siemens) |
![]() |
Region | Berlin |
Country | Germany | |
City | n. a. Berlin | |
Address record changed: 2022-03-23 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: InfanDx AG. (3/15/22). "Press Release: Neonatal Diagnostics Company InfanDx AG Closes Oversubscribed Second Tranche of Series A". Cologne & Boston, MA. | ||
Record changed: 2024-12-29 |
Advertisement

More documents for InfanDx (Group)
- [1] High-Tech Gründerfonds Management GmbH. (12/9/24). "Press Release: HTGF Strengthens Life Science Expertise – Dr. Achim Plum to Become New Managing Director". Bonn....
- [2] InfanDx AG. (3/28/23). "Press Release: InfanDx AG Revises Strategy and Broadens Diagnostics Pipeline for Child Health". Cologne, Berlin & Boston, MA....
- [3] InfanDx AG. (9/1/22). "Press Release: InfanDx AG Appoints Nicole Witzmann as Chief Financial Officer". Cologne, Berlin & Boston, MA....
- [4] InfanDx AG. (3/15/22). "Press Release: Neonatal Diagnostics Company InfanDx AG Closes Oversubscribed Second Tranche of Series A". Cologne & Boston, MA....
- [5] InfanDx AG. (8/4/21). "Press Release: Neonatal Diagnostics Company InfanDx AG Appoints Dr. Gunter Weiss as COO". Cologne....
- [6] InfanDx AG. (7/13/21). "Press Release: Neonatal Diagnostics Company InfanDx AG Completes Series A Funding". Cologne....
- [7] InfanDx AG. (3/11/21). "Press Release: Neonatal Diagnostics Company InfanDx Closes Interim Financing Round". Cologne....
- [8] InfanDx AG. (2/4/21). "Press Release: Neonatal Diagnostics Company InfanDx Appoints Achim Plum as CEO". Cologne....
- [9] InfanDx AG. (4/24/19). "Press Release: InfanDx AG Closes 5.3 Mio EUR Financing". Cologne & Bonn....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top